Skip to content

Efficacy Study on Silver-coated ETT Cleaned With a Novel Device

Silver-coated Endotracheal Tube Cleaned With a Novel Mechanism for Secretion Removal: a Randomized Controlled Clinical Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02120001
Enrollment
40
Registered
2014-04-22
Start date
2014-06-30
Completion date
2015-08-31
Last updated
2017-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill, Ventilator Associated Pneumonia

Keywords

Medical Devices, Ventilator-Associated Pneumonia (VAP), Ventilator-Associated Events (VAE), Endotracheal Tube, Microbial Diversity, Drug-Resistance, biofilms, endotracheal intubation, mechanical ventilation

Brief summary

The purpose of this study is to test the efficacy of a novel cleaning device in keeping silver-coated endotracheal tubes free from bacterial colonization.

Detailed description

Several studies have suggested that biofilm formation inside the ETT plays a pivotal role in VAP development and drug-resistance induction. Silver-coated ETT have proven effective in delaying but not in preventing ETT colonization and biofilm formation, due to a barrier effect of biofilm and accumulated debris. Advanced ETT cleaning devices are able to remove debris and biofilm and reduce the total ETT microbial load to a certain extent. The Investigators hypothesize that the routine use of endOclear in patients intubated with a silver-coated ETT will reduce ETT microbial colonization. The Investigators therefore want to assess the reduction of ETT microbial colonization in patients intubated with a silver-coated ETT and cleaned with endOclear compared to the current standard of care of silver-coated ETT (blind suctioning). They plan to achieve this result by analyzing the tubes of each enrolled patient after it has been removed, either because the patient does not need it anymore due to his/her better clinical conditions, or because there is a need of tracheostomy or because he/she dies. Specifically they will analyze how the endOclear cleaning maneuver affects microbial colonization in the inner layer of the ETT and how this can determine distal airway inoculation and, ultimately, VAP development. Specific AIM #1: Investigators will test the hypothesis that routine use of endOclear in patients intubated with a silver-coated ETT will reduce ETT microbial colonization. Specific AIM #2: Investigators will test the hypothesis that keeping ETTs free from microbial colonization will prevent septic inoculation of distal airways Specific AIM #3: Investigators will test the hypothesis that prevention of ETT biofilm development will reduce drug resistance rates found in ETT and distal airways isolates The investigators will conduct a randomized clinical trial on 40 patients intubated with silver-coated ETT and randomized to receive standard ETT cleaning vs cleaning with the endOclear device.

Interventions

EndOclear is a commercially available device. It consists of an endotracheal tube cleaning apparatus with a flexible central tube and a cleaning device at its distal end. In operation, the collapsed cleaning apparatus is inserted into the ETT through a Y-shaped connector. The device is then expanded by a safety toggle protected trigger mechanism that, when fired, presses the device's smooth silicone disc against the inside surface of the endotracheal tube. The cleaning apparatus is then pulled out of the endotracheal tube removing mucus deposits and secretions. We plan to add the use of endOclear to the standard ICU practice, scheduling the systematic use of the device every 8 hours for the whole intubation period.

Sponsors

Brigham and Women's Hospital
CollaboratorOTHER
Rhode Island Hospital
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admission to Medical, Surgical or Neuro ICU * Subjects must be enrolled within 24 hours from intubation * Subjects expected to be intubated for at least 48 hours or longer * Subjects have been intubated with a silver-coated ETT

Exclusion criteria

* Current and past participation in another interventional trial conflicting with the present study * Pregnant women * Prisoner status

Design outcomes

Primary

MeasureTime frameDescription
Endotracheal Tube ColonizationAt extubation (an expected average of 7 days)Discarded ETTs will be collected after extubation and sent for quantitative and qualitative microbiological analysis after silver ion inactivation. Qualitative analysis was based on confocal microscopy, we described visually the distribution of microbial colonization. However, we did not report numerical value because the confounding factors (i.e., number and length of devices).

Secondary

MeasureTime frameDescription
Microbiological Colonization of Distal AirwaysAt extubation (An expected average of 7 days)Investigators will collect data about distal airways samples performed for clinical reasons during the study period and, in addition, investigators will collect a specimen from the distal airways immediately before extubation.

Countries

United States

Participant flow

Recruitment details

Four patients were found ineligible.

Participants by arm

ArmCount
ETT Cleaning Maneuver
Patients randomized to the treatment group will undergo an ETT cleaning maneuver with endOclear three times a day (every 8 hours) for the whole intubation period in addition to the standard of care.
17
Standard of Care
In the protocol no intervention is planned for the control group, which will therefore be treated with blind suctioning as per caregiver clinical decision.
19
Total36

Baseline characteristics

CharacteristicStandard of CareTotalETT Cleaning Maneuver
Age, Continuous61.2 years
STANDARD_DEVIATION 3.5
63.2 years
STANDARD_DEVIATION 4
65.6 years
STANDARD_DEVIATION 4.1
Race/Ethnicity, Customized
Asian
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Black/African American
2 Participants3 Participants1 Participants
Race/Ethnicity, Customized
Unknown or Not Reported
3 Participants4 Participants1 Participants
Race/Ethnicity, Customized
White
14 Participants28 Participants14 Participants
Region of Enrollment
United States
19 participants36 participants17 participants
Sex: Female, Male
Female
10 Participants14 Participants4 Participants
Sex: Female, Male
Male
9 Participants22 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 170 / 19
serious
Total, serious adverse events
0 / 170 / 19

Outcome results

Primary

Endotracheal Tube Colonization

Discarded ETTs will be collected after extubation and sent for quantitative and qualitative microbiological analysis after silver ion inactivation. Qualitative analysis was based on confocal microscopy, we described visually the distribution of microbial colonization. However, we did not report numerical value because the confounding factors (i.e., number and length of devices).

Time frame: At extubation (an expected average of 7 days)

ArmMeasureValue (MEAN)Dispersion
ETT Cleaning ManeuverEndotracheal Tube Colonization0.9 Log colony form unit (CFU)/ mLStandard Deviation 1.2
Standard of CareEndotracheal Tube Colonization1.6 Log colony form unit (CFU)/ mLStandard Deviation 1.2
Secondary

Microbiological Colonization of Distal Airways

Investigators will collect data about distal airways samples performed for clinical reasons during the study period and, in addition, investigators will collect a specimen from the distal airways immediately before extubation.

Time frame: At extubation (An expected average of 7 days)

ArmMeasureValue (MEAN)Dispersion
ETT Cleaning ManeuverMicrobiological Colonization of Distal Airways4.2 Log colony form unit (CFU)/ mLStandard Deviation 3.8
Standard of CareMicrobiological Colonization of Distal Airways4.8 Log colony form unit (CFU)/ mLStandard Deviation 4

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026